The effect of core composition in biodegradable oligomeric micelles as taxane formulations

被引:61
作者
Carstens, Myrra G. [1 ,2 ]
de Jong, Pascal H. J. L. F. [1 ]
van Nostrum, Cornelus F. [1 ]
Kemmink, Johan [3 ]
Verrijk, Ruud [2 ]
De Leede, Leo G. J. [2 ]
Crornmelin, Daan J. A. [1 ]
Hennink, Wim E. [1 ]
机构
[1] Univ Utrecht, Dept Pharmaceut, UIPS, NL-3508 TB Utrecht, Netherlands
[2] OctoPlus NV, Leiden, Netherlands
[3] Univ Utrecht, Dept Med Chem, Utrecht, Netherlands
关键词
formulation; polymeric drug carrier; micelle; poly(ethylene glycol)-oligo(epsilon-caprolactone); paclitaxel; docetaxel; particle size; particle stability; drug solubilisation; core composition;
D O I
10.1016/j.ejpb.2007.08.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Docetaxel (DCTX) and paclitaxel (PTX) are very potent anti-cancer drugs, but the currently marketed formulations, Taxotere(R) and Taxol(R), respectively, are associated with vehicle-related toxicity. An attractive alternative to formulate these hydrophobic cytotoxic agents are polymeric micelles. In this study, the loading of taxanes into oligomeric micelles composed of mPEG750-b-oligo(epsilon-caprolactone)(5) (mPEG750-b-OCL5) with a hydroxyl (OH), benzoyl (Bz) or naphthoyl (Np) end group was investigated. Next, the release characteristics and cytotoxicity of the loaded micelles were studied. MPEG750-b-OCL5-OH micelles loaded with taxanes formed unstable particles with rapid leakage of the drug. In contrast, the presence of an aromatic end group (Bz or Np) resulted in the formation of small (10 nm), almost monodisperse micelles with stable encapsulation of 10% (w/w) of PTX or DCTX. This was ascribed to a better compatibility between the micellar core and the drug as compared to the oligomers with the hydroxyl end group. H-1 NMR studies showed that the micellar core was liquid, and that PTX was molecularly dissolved in the core. The in vitro stability was studied in PBS at 37 degrees C, which showed that leakage of PTX from 10% and 5% (w/w) loaded mPEG750-b-OCL5-Bz micelles started after 8 and 24 It, respectively. The presence of albumin did not affect the stability, suggesting that the micelles are not destabilised and the drug was not extracted from the micellar core by this protein. The in vitro cytotoxic effect of the taxane-loaded micelles on C26 carcinoma cells was comparable to that of the commercial formulations, but the empty micelles were far less toxic than the Cremophor EL(R) vehicle. The results show that mPEG-b-oligo(epsilon-caprolactone) micelles hold good promise for the formulation of taxanes. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:596 / 606
页数:11
相关论文
共 60 条
[51]   Role of formulation vehicles in taxane pharmacology [J].
van Zuylen, L ;
Verweij, J ;
Sparreboom, A .
INVESTIGATIONAL NEW DRUGS, 2001, 19 (02) :125-141
[52]   Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability [J].
Watanabe, M ;
Kawano, K ;
Yokoyama, M ;
Opanasopit, P ;
Okano, T ;
Maitani, Y .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 308 (1-2) :183-189
[53]   Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice [J].
Weissig, V ;
Whiteman, KR ;
Torchilin, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (10) :1552-1556
[54]  
WILCHEK M, 1982, BIOCHEM INT, V4, P629
[55]   A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer [J].
Xie, Zhigang ;
Guan, Huili ;
Chen, Xuesi ;
Lu, Changhai ;
Chen, Li ;
Hu, Xiuli ;
Shi, Quan ;
Jing, Xiabin .
JOURNAL OF CONTROLLED RELEASE, 2007, 117 (02) :210-216
[56]   Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles in aqueous milieu [J].
Yamamoto, Y ;
Yasugi, K ;
Harada, A ;
Nagasaki, Y ;
Kataoka, K .
JOURNAL OF CONTROLLED RELEASE, 2002, 82 (2-3) :359-371
[57]   Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin [J].
Yokoyama, M ;
Opanasopit, P ;
Okano, T ;
Kawano, K ;
Maitani, Y .
JOURNAL OF DRUG TARGETING, 2004, 12 (06) :373-384
[58]   An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel [J].
Zhang, XC ;
Burt, HM ;
VonHoff, D ;
Dexter, D ;
Mangold, G ;
Degen, D ;
Oktaba, AM ;
Hunter, WL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (01) :81-86
[59]   Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel [J].
Zhang, XC ;
Burt, HM ;
Mangold, G ;
Dexter, D ;
VonHoff, D ;
Mayer, L ;
Hunter, WL .
ANTI-CANCER DRUGS, 1997, 8 (07) :696-701
[60]   Development of amphiphilic diblock copolymers as micellar carriers of taxol [J].
Zhang, XC ;
Jackson, JK ;
Burt, HM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 132 (1-2) :195-206